Bone needle could save lives when veins collapse in blood disease emergencies

NCT ID NCT07239375

Recruiting now Knowledge-focused Sponsor: Shanxi Bethune Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at using a needle placed into the bone marrow (intraosseous infusion) to give fluids and medicines quickly to critically ill patients with blood diseases. Researchers will enroll 52 adults aged 18-65 to see how often the first attempt works and how safe it is. The goal is to find a reliable backup when standard IV access is not possible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that intraosseous infusion is a reliable emergency option for blood disease patients when standard IV access fails.
What could go wrong: This is a small, early observational study with only 52 participants. It is not designed to prove the technique works better than standard care, and complications like infection or fat embolism are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematologic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRAOSSEOUS INFUSIONS

Contacts and locations

Locations

Shanxi Bethune Hospital
RECRUITING

Taiyuan, Shanxi, 030000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.